Promoting the Use of CPAP Therapy Among OSA Patients
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Behavioral: CPAP4HealthySleep system
- Registration Number
- NCT04372329
- Lead Sponsor
- Sarah Alismail
- Brief Summary
Obstructive sleep apnea (OSA) is the most common sleep breathing disorder in the U.S. Continuous Positive Airway Pressure (CPAP) therapy is the most effective treatment for OSA. However, up to 50% of patients who accept using CPAP therapy fail to adhere to it. This study will evaluate an information systems (IS)-based solution that sends tailored, motivational, educational messages and tailored feedback messages to promote CPAP usage among noncompliant OSA patients. The primary aim of this study is to determine the efficacy of the proposed IS solution and its effect on fostering the use of CPAP therapy among OSA patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 59
- Clinical diagnosis of OSA
- Prescribed treatment of CPAP therapy
- Possession of a mobile phone that has multimedia messaging capabilities
- Capacity to consent.
- Unable to speak and read English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description CPAP4HealthySleep: System 2 (BABA) CPAP4HealthySleep system Participants in this group will first receive weekly feedback messages only (one message per week) notifying participants of their CPAP usage for two weeks (type B). Next, they will receive six tailored educational messages per week and weekly feedback messages notifying participants of their CPAP usage on the seventh day for two weeks (type A), re-introduction of type B for another two weeks, followed by re-introduction of type A for two weeks. CPAP4HealthySleep: System 1 (ABAB) CPAP4HealthySleep system Participants in this group will first receive six tailored educational messages per week and weekly feedback messages notifying participants of their CPAP usage on the seventh day for two weeks (type A). Next, they will receive weekly feedback messages only (one message per week) notifying participants of their CPAP usage for two weeks (type B), re-introduction of type A for another two weeks, followed by re-introduction of type B for two weeks.
- Primary Outcome Measures
Name Time Method CPAP compliance 19 weeks Compliance of CPAP use characterized by mask-on time at the prescribed pressure for ≥ 4 hours/day for 70% of monitored nights.
Change in CPAP usage During 19 weeks The average number of hours per week of CPAP usage.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Pomona Valley Hospital Medical Center Adults and Children Sleep Disorders Center
🇺🇸Claremont, California, United States